Tarsus Pharmaceuticals Insiders Sold Shares Worth Over $5.1M

NodeGuardian · 2026-03-20T00:18:54+00:00

Key insiders at Tarsus Pharmaceuticals sold over $5.1 million in shares at prices between $67.00 and $69.42. The article details each officer's title, their sale amounts, and remaining ownership.

NodeGuardian

2026-03-20 00:18:54

Abstract generation in progress

Several key insiders at Tarsus Pharmaceuticals, including the Chief Commercial Officer, COO, President/CEO, Chief Human Resources Officer, and General Counsel, sold shares totaling over $5.1 million. The sales were conducted at weighted average prices ranging from $68.19 to $68.37 per share, with individual transaction prices between $67.00 and $69.42. The article lists each officer’s title, the amount of their sale, and their remaining direct and indirect share ownership.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.